• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向三阴性乳腺癌癌干细胞的转化药物

Translational drugs targeting cancer stem cells in triple-negative breast cancer.

作者信息

Oliveira Felipe P de, Nogueira Mateus L, Galvão Alexandre F C, Dias Rosane B, Bezerra Daniel P

机构信息

Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Salvador, Bahia 40296-710, Brazil.

Department of Biological Sciences, State University of Feira de Santana, Feira de Santana, Bahia 44036-900, Brazil.

出版信息

Mol Ther Oncol. 2025 Jun 13;33(3):201008. doi: 10.1016/j.omton.2025.201008. eCollection 2025 Sep 18.

DOI:10.1016/j.omton.2025.201008
PMID:40687439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12269295/
Abstract

Triple-negative breast cancer (TNBC) is defined by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). It is unresponsive to targeted therapy and is associated with a high degree of malignancy, a high propensity for metastasis, high recurrence rates, and poor prognosis. In the modern concept of cancer biology, a subset of cancer cells known as tumor-initiating cells or cancer stem cells (CSCs) are defined as essential for the development and dissemination of cancer. These are a population of highly tumorigenic and self-renewing pluripotent cells that are inherently associated to the initiation, dissemination, relapse, and development of drug resistance. Specifically, some cell signaling pathways may affect the ability of CSCs to self-renew, differentiate, proliferate, and survive. To guide future research, in this review, we address compounds that target cell signaling and eliminate TNBC stem cells. Potential translational inhibitors of the Hedgehog, nuclear factor κB (NF-κB), Wnt, Notch, Hippo, TGF-β, JAK/STAT, and PI3K/AKT/mTOR cell signaling pathways are discussed, with a focus on TNBC stem cell eradication.

摘要

三阴性乳腺癌(TNBC)的定义是缺乏雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)的表达。它对靶向治疗无反应,并且与高度恶性、高转移倾向、高复发率和不良预后相关。在现代癌症生物学概念中,一种被称为肿瘤起始细胞或癌症干细胞(CSCs)的癌细胞亚群被定义为癌症发生和扩散所必需的。这些是一群具有高度致瘤性和自我更新能力的多能细胞,它们与肿瘤的起始、扩散、复发和耐药性的发展内在相关。具体而言,一些细胞信号通路可能会影响癌症干细胞的自我更新、分化、增殖和存活能力。为指导未来的研究,在本综述中,我们探讨了靶向细胞信号并消除TNBC干细胞的化合物。讨论了Hedgehog、核因子κB(NF-κB)、Wnt、Notch、Hippo、TGF-β、JAK/STAT和PI3K/AKT/mTOR细胞信号通路的潜在翻译抑制剂,重点是根除TNBC干细胞。

相似文献

1
Translational drugs targeting cancer stem cells in triple-negative breast cancer.靶向三阴性乳腺癌癌干细胞的转化药物
Mol Ther Oncol. 2025 Jun 13;33(3):201008. doi: 10.1016/j.omton.2025.201008. eCollection 2025 Sep 18.
2
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.
3
PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.用于治疗雌激素受体阳性晚期乳腺癌的蛋白酶靶向嵌合体(PROTAC)雌激素受体降解剂
Target Oncol. 2025 May;20(3):431-444. doi: 10.1007/s11523-025-01137-5. Epub 2025 May 6.
4
Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.三阴性乳腺癌上皮-间质转化的靶向治疗方法
Front Oncol. 2024 Oct 10;14:1431418. doi: 10.3389/fonc.2024.1431418. eCollection 2024.
5
Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.免疫组织化学检测切除修复交叉互补基因1(ERCC1)对三阴性乳腺癌新辅助化疗反应的预测价值
Breast J. 2025 Feb 18;2025:8410670. doi: 10.1155/tbj/8410670. eCollection 2025.
6
Inhibition of Interleukin-8/C-X-C Chemokine Receptor 2 Signaling Axis Prevents Tumor Growth and Metastasis in Triple-Negative Breast Cancer Cells.抑制白细胞介素-8/C-X-C趋化因子受体2信号轴可预防三阴性乳腺癌细胞的肿瘤生长和转移。
Pharmacology. 2025 Apr 4:1-13. doi: 10.1159/000545659.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
The PI3K/Akt/mTOR Signaling Pathway in Triple-Negative Breast Cancer: A Resistance Pathway and a Prime Target for Targeted Therapies.三阴性乳腺癌中的PI3K/Akt/mTOR信号通路:一条耐药通路及靶向治疗的主要靶点
Cancers (Basel). 2025 Jul 3;17(13):2232. doi: 10.3390/cancers17132232.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review.曲妥珠单抗德鲁替康单药治疗人表皮生长因子受体2突变的三阴性转移性乳腺癌患者的长期持久反应:长期随访及文献综述
J Med Cases. 2025 Jun 16;16(6):212-221. doi: 10.14740/jmc5136. eCollection 2025 Jun.

引用本文的文献

1
Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment.天然免疫细胞和细胞因子在塑造乳腺癌微环境中的双重作用。
Front Immunol. 2025 Aug 20;16:1654947. doi: 10.3389/fimmu.2025.1654947. eCollection 2025.
2
Hepatocellular carcinoma stem cells: the current state of small molecule-based inhibitors.肝细胞癌干细胞:基于小分子抑制剂的研究现状
Cell Death Dis. 2025 Sep 1;16(1):666. doi: 10.1038/s41419-025-07983-5.

本文引用的文献

1
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer.细胞外基质硬度:肿瘤进展机制及癌症治疗潜力
Exp Hematol Oncol. 2025 Apr 10;14(1):54. doi: 10.1186/s40164-025-00647-2.
2
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction.癌症干细胞与肿瘤相关巨噬细胞在肿瘤进展中的协同作用:相互作用机制及剖析其表型与相互作用的先进生物信息学工具
Front Immunol. 2025 Feb 6;16:1529847. doi: 10.3389/fimmu.2025.1529847. eCollection 2025.
3
Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research.
癌症干细胞的靶向治疗:mTOR 在临床前和临床研究中的抑制作用。
Cell Death Dis. 2024 Sep 30;15(9):696. doi: 10.1038/s41419-024-07077-8.
4
"The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial".纳米姜黄素补充剂对乳腺癌患者阿霉素诱导的心脏毒性的保护作用;一项随机双盲临床试验
J Oncol Pharm Pract. 2024 Sep 2:10781552241277958. doi: 10.1177/10781552241277958.
5
Inhibition of Cancer Stem-like Cells by Curcumin and Other Polyphenol Derivatives in MDA-MB-231 TNBC Cells.姜黄素和其他多酚衍生物对 MDA-MB-231 TNBC 细胞中癌症干细胞样细胞的抑制作用。
Int J Mol Sci. 2024 Jul 6;25(13):7446. doi: 10.3390/ijms25137446.
6
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer.PI3K/AKT/mTOR 信号通路:三阴性乳腺癌的重要驱动因子和治疗靶点。
Breast Cancer. 2024 Jul;31(4):539-551. doi: 10.1007/s12282-024-01567-5. Epub 2024 Apr 17.
7
TGF-β signaling in health, disease, and therapeutics.TGF-β 信号在健康、疾病和治疗中的作用。
Signal Transduct Target Ther. 2024 Mar 22;9(1):61. doi: 10.1038/s41392-024-01764-w.
8
Piplartine eliminates CD34 + AML stem/progenitor cells by inducing oxidative stress and suppressing NF-κB signalling.派普拉丁通过诱导氧化应激和抑制核因子κB信号传导来消除CD34 +急性髓系白血病干细胞/祖细胞。
Cell Death Discov. 2024 Mar 19;10(1):147. doi: 10.1038/s41420-024-01909-4.
9
Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study.灵芝对早期三阴性乳腺癌的生存益处:一项真实世界研究
Recent Pat Anticancer Drug Discov. 2024 Feb 20. doi: 10.2174/0115748928282946240111114448.
10
Transforming growth factor-β receptors: versatile mechanisms of ligand activation.转化生长因子-β 受体:配体激活的多种机制。
Acta Pharmacol Sin. 2024 Jul;45(7):1337-1348. doi: 10.1038/s41401-024-01235-6. Epub 2024 Feb 13.